Trials / Recruiting
RecruitingNCT06167356
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- IRCCS San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.
Detailed description
Each patient will be followed for approximately 10 years starting from the date of surgery. The patient may be contacted for yearly follow-up through one of the preferred methods indicated (phone call, email or home address) which will be carried out by the staff of the Urology Department. The data for each patient will then be transferred to the database itself. The data collected will be handled follwing the most strict GCPs and privacy norms. The data entered will concern: * period before hospitalization (symptoms, clinical data) and completion of a pre-surgery questionnaire * hospitalization period with all its related data * questionnaires relating to quality of life which will be administered to the patient once a year according to the preferred method expressed by the patient in the informed consent.
Conditions
- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Neoplasms
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Bladder Cancer
- Bladder Disease
- Bladder Neoplasm
- Bladder Urothelial Carcinoma
- Bladder Cancer Stage I, With Cancer in Situ
- Bladder Cancer Recurrent
- Bladder Urothelial Carcinoma in Situ
- Bladder Urothelial Dysplasia
Timeline
- Start date
- 2013-11-27
- Primary completion
- 2063-11-27
- Completion
- 2063-11-27
- First posted
- 2023-12-12
- Last updated
- 2023-12-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06167356. Inclusion in this directory is not an endorsement.